97 related articles for article (PubMed ID: 26103957)
1. Serum Leptin Levels and Well-Differentiated Thyroid Cancer: A True Association: Reply.
Abdel-Aziz TE; Rehem RA; Elwafa WA
World J Surg; 2015 Sep; 39(9):2367. PubMed ID: 26103957
[No Abstract] [Full Text] [Related]
2. Importance of factors affecting serum leptin levels.
Sertoglu E
World J Surg; 2015 Jun; 39(6):1587-8. PubMed ID: 25561198
[No Abstract] [Full Text] [Related]
3. Study of serum leptin in well-differentiated thyroid carcinoma: correlation with patient and tumor characteristics.
Rehem RA; Elwafa WA; Elwafa RA; Abdel-Aziz TE
World J Surg; 2014 Oct; 38(10):2621-7. PubMed ID: 24867470
[TBL] [Abstract][Full Text] [Related]
4. [Determination of serum thyroglobulin in differentiated thyroid cancer. A review and 3 cases].
Feldt-Rasmussen U; Hansen HS; Rasmusson B
Ugeskr Laeger; 1983 Apr; 145(15):1132-6. PubMed ID: 6879741
[No Abstract] [Full Text] [Related]
5. [Medullary carcinoma of the thyroid gland with Cushing's syndrome].
Dirschmid K; Weichselbaumer W
Monatsschr Ohrenheilkd Laryngorhinol; 1972 Oct; 106(10):491-7. PubMed ID: 4645416
[No Abstract] [Full Text] [Related]
6. [Endocrinological and clinicopathological studies on medullary thyroid carcinoma. Part 2: Biological behavior of the medullary thyroid carcinoma and its surgical implications (author's transl)].
Obara T
Nihon Gan Chiryo Gakkai Shi; 1977 Mar; 12(1):12-23. PubMed ID: 559026
[No Abstract] [Full Text] [Related]
7. Elevated calcitonin and procalcitonin levels in nonmedullary benign and malignant thyroid nodules.
Giovanella L; Maffioli M; Suriano S; Dorizzi RM
Clin Endocrinol (Oxf); 2010 Jun; 72(6):852-3. PubMed ID: 19863575
[No Abstract] [Full Text] [Related]
8. Mixed medullary and papillary thyroid carcinoma: A stepwise diagnosis.
Myoteri D; Dellaportas D; Carvounis E; Kondi-Pafiti A; Vassiliou I
J BUON; 2016; 21(6):1561-1562. PubMed ID: 28039723
[No Abstract] [Full Text] [Related]
9. [Insular carcinoma of the thyroid. Apropos of a case and review of the literature].
Auge B; Rodier JF; Pusel J; Janser JC
Arch Anat Cytol Pathol; 1993; 41(3-4):124-8. PubMed ID: 8279853
[TBL] [Abstract][Full Text] [Related]
10. Serum thyroglobulin measurements: clinical utility and technical limitations in the management of patients with differentiated thyroid carcinomas.
Spencer CA
Endocr Pract; 2000; 6(6):481-4. PubMed ID: 11155225
[No Abstract] [Full Text] [Related]
11. Thyroglobulin and recurrence of thyroid cancer.
Miwanitkit V
S Afr J Surg; 2012 Mar; 50(2):52. PubMed ID: 22622106
[No Abstract] [Full Text] [Related]
12. Thyroglobulin - what is the postoperative threshold for the suspicion of thyroid cancer recurrence in the absence of anti-Tg antibody measurement?
Papageorgiou MS; Liratzopoulos N; Minopoulos G; Manolas KJ
S Afr J Surg; 2011 Aug; 49(3):118-22. PubMed ID: 21933495
[TBL] [Abstract][Full Text] [Related]
13. Treatment of "locally advanced" well-differentiated thyroid carcinomas.
Falvo L; Catania A; Grilli P; Di Matteo FM; De Antoni E
Ann Ital Chir; 2004; 75(1):17-21. PubMed ID: 15283382
[TBL] [Abstract][Full Text] [Related]
14. Contemporary management of differentiated thyroid carcinoma.
Wein RO; Weber RS
Otolaryngol Clin North Am; 2005 Feb; 38(1):161-78, x. PubMed ID: 15649506
[TBL] [Abstract][Full Text] [Related]
15. Leptin levels in thyroid cancer.
Akinci M; Kosova F; Cetin B; Aslan S; Ari Z; Cetin A
Asian J Surg; 2009 Oct; 32(4):216-23. PubMed ID: 19892624
[TBL] [Abstract][Full Text] [Related]
16. [A case report of a giant cell carcinoma of the thyroid].
Murakami N; Kawaura Y; Sasaki M; Munemoto Y; Iwa T; Nonomura A
Gan No Rinsho; 1989 Jul; 35(8):927-32. PubMed ID: 2746867
[TBL] [Abstract][Full Text] [Related]
17. [The special characteristics of differentiated thyroid carcinoma and the controversies in the surgical treatment on the patients with it].
Wen SX; Wang BQ; Huangfu H; Zhang CM; Gao W
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 52(4):302-304. PubMed ID: 28441813
[No Abstract] [Full Text] [Related]
18. Lack of Association between Serum Adiponectin/Leptin Levels and Medullary Thyroid Cancer.
Abooshahab R; Yaghmaei P; Ghadaksaz HG; Hedayati M
Asian Pac J Cancer Prev; 2016; 17(8):3861-4. PubMed ID: 27644630
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of serum Interleukin-1 receptor antagonist levels as a diagnostic and prognostic assay in surgical patients.
Kapoor S
Langenbecks Arch Surg; 2009 Mar; 394(2):401-2; author reply 403. PubMed ID: 18825404
[No Abstract] [Full Text] [Related]
20. Conventional withdrawal of thyroid hormone before radioiodine therapy in differentiated thyroid carcinoma: how frequently are adequately raised TSH levels attained?
McLaughlin CM; Hunter SJ; Bell PM; McCance DR; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 2008 Jul; 69(1):169-70. PubMed ID: 18042175
[No Abstract] [Full Text] [Related]
[Next] [New Search]
